zaleplon

Generic: zaleplon

Labeler: aurobindo pharma limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name zaleplon
Generic Name zaleplon
Labeler aurobindo pharma limited
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

zaleplon 5 mg/1

Manufacturer
Aurobindo Pharma Limited

Identifiers & Regulatory

Product NDC 65862-214
Product ID 65862-214_36ab371f-c2fe-4c1d-ad60-801b8f118f4e
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA078829
DEA Schedule civ
Listing Expiration 2026-12-31
Marketing Start 2008-06-06

Pharmacologic Class

Established (EPC)
gamma-aminobutyric acid a receptor agonist [epc]
Mechanism of Action
gaba a agonists [moa]
Physiologic Effect
central nervous system depression [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 65862214
Hyphenated Format 65862-214

Supplemental Identifiers

RxCUI
313761 313762
UNII
S62U433RMH
NUI
N0000183360 N0000000196 N0000175728

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name zaleplon (source: ndc)
Generic Name zaleplon (source: ndc)
Application Number ANDA078829 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 5 mg/1
source: ndc
Packaging
  • 100 CAPSULE in 1 BOTTLE (65862-214-01)
  • 500 CAPSULE in 1 BOTTLE (65862-214-05)
source: ndc

Packages (2)

65862-214-01 100 CAPSULE in 1 BOTTLE (65862-214-01) 65862-214-05 500 CAPSULE in 1 BOTTLE (65862-214-05)

Ingredients (1)

zaleplon (5 mg/1)

Linked Drug Pages (1)

ZALEPLON ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "36ab371f-c2fe-4c1d-ad60-801b8f118f4e", "openfda": {"nui": ["N0000183360", "N0000000196", "N0000175728"], "unii": ["S62U433RMH"], "rxcui": ["313761", "313762"], "spl_set_id": ["e092f3ca-bf44-4568-a72c-3fb2cf5b192b"], "pharm_class_pe": ["Central Nervous System Depression [PE]"], "pharm_class_epc": ["gamma-Aminobutyric Acid A Receptor Agonist [EPC]"], "pharm_class_moa": ["GABA A Agonists [MoA]"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (65862-214-01)", "package_ndc": "65862-214-01", "marketing_start_date": "20080606"}, {"sample": false, "description": "500 CAPSULE in 1 BOTTLE (65862-214-05)", "package_ndc": "65862-214-05", "marketing_start_date": "20080606"}], "brand_name": "ZALEPLON", "product_id": "65862-214_36ab371f-c2fe-4c1d-ad60-801b8f118f4e", "dosage_form": "CAPSULE", "pharm_class": ["Central Nervous System Depression [PE]", "GABA A Agonists [MoA]", "gamma-Aminobutyric Acid A Receptor Agonist [EPC]"], "product_ndc": "65862-214", "dea_schedule": "CIV", "generic_name": "ZALEPLON", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ZALEPLON", "active_ingredients": [{"name": "ZALEPLON", "strength": "5 mg/1"}], "application_number": "ANDA078829", "marketing_category": "ANDA", "marketing_start_date": "20080606", "listing_expiration_date": "20261231"}